1Hruba n RH, Takaori K, Klimstra DS, Adsay NV, Albores -Saav- edra J, Biankin AV, Biankin SA, Compton C, Fukushima N, Fu- rukawa T, Goggins M, Kato Y, Kloppel G, Long'necker DS, Ltlttges J, Maitra A, Offerhans GJ, Shimizu M, Yonezawa S. An illustrated consensus on the classification of pancreatic intmepi- thelial neoplasia and intreductal papillary mucinous neo- plasms. Am J Surg Pathol 2004,28:977 -987.
2Mujica VR, Barkin JS, Go VL Acute pancreatitis secondary to pancreatic carcinoma. Study Group Participants. Pancreas 2000, 21 : 329 -332.
3Kala Z, V(xlek V, H]avsa J, Hana K, Vdnovt A. The role of CT and endoscopic ultrasound in preoperative staging of pancreatic cancer. Eur J Radiol 2007,62 : 166 - 169.
4Schima W. MRI of the pancreas: tumours and tumoumimulating processes. Cancer Imaging,2006,6 : 199 - 203.
5Eloubeidi MA, Varedarajulu S, DesaI S, Shirley R, Heslin MJ, Mehra M, Arnoletti JP, Ehoumi, Wilcox CM, Vickcrs SM. Aprospective evaluation of an algorithm incorpora ring rou- tine preoperative endoscopic ultrasound - guided fine needle as- piration in suspected pancreatic cancer. J Gastrointest Surg 2007,11:813 - 819.
6Butturini G, Crippa S, Bassi C, Salvia R, Piccoli M, Pederzoli P. The role of laparoscopy in advanced pancreatic cancer diagno- sis. Dig Surg 2007,24:33 -37.
9Ishikawa , Ohhigashi , Sasaki , et al. Extended pancreatectomy and liver perfusion chemotherapy for reseclable a - denocareino- ma of the pancreas [J]. Digestion, 1990:60 ( 11 ) 135 - 138.
10Burris H A 3rd,Moore M J,Adnersen J,et al. Improvements in survival and clinical benefit with gemciatbine as first - line with gemciathine as first - line therapy for patients with advanc - ed pancreas canc -er a randomized trial [J]. J Clin Oncol, 1997, 15(6) :2403 -2413.
